Bianchetti G, Elghozi J L, Gomeni R, Meyer P, Morselli P L
J Pharmacol Exp Ther. 1980 Sep;214(3):682-7.
The kinetics of distribution of di-propranolol (P) to various organs and tissues were studied in the rat after an i.v. dose of 2 mg/kg. The disposition of the drug can be adequately described by a two-compartment open model with a distribution half-life of 4.8 min, a terminal blood half-life of 63 min and an apparent volume of distribution beta of 8.5 liters/kg. Higher tissue concentrations were found to be present in heart, brain and kidney. Although the disappearance rate of P from abdominal aorta, muscles, adipose tissue and whole brain paralleled that of blood, the elimination rate constant for atria and kidney was significantly reduced suggesting a specific binding of P. After an i.v. dose of 5 mg/kg, P distributed rapidly to various brain areas following a vascularity pattern with higher concentrations in cortical areas of earlier times. An equilibrium between various brain areas was observed at 2 to 3 hr after dosing. There was a parallel decay of P concentrations in the blood and in cortical areas, whereas the elimination constants were significantly reduced for hypothealamic nuclei and the medulla (C1 and C2), suggesting again a specific binding. The data show that distribution, uptake and tissue binding of P in various peripheral organs and discrete brain areas is not a uniform process and they could give a partial explanation on the discrepancies observed clinically between the pharmacodynamics and pharmacokinetics. The data also suggest the possibility of specific P binding sites in heart, kidney and brain which could be of relevance for its mode of action.
在大鼠静脉注射2mg/kg剂量的二异丙醇(P)后,研究了其在各个器官和组织中的分布动力学。该药物的处置可用二室开放模型充分描述,分布半衰期为4.8分钟,终末血半衰期为63分钟,表观分布容积β为8.5升/千克。发现心脏、大脑和肾脏中的组织浓度较高。尽管P从腹主动脉、肌肉、脂肪组织和全脑中的消失速率与血液中的平行,但心房和肾脏的消除速率常数显著降低,表明P存在特异性结合。静脉注射5mg/kg剂量后,P按照血管分布模式迅速分布到各个脑区,早期皮质区域浓度较高。给药后2至3小时观察到各个脑区之间达到平衡。血液和皮质区域中P浓度呈平行下降,而下丘脑核和延髓(C1和C2)的消除常数显著降低,再次表明存在特异性结合。数据表明,P在各种外周器官和离散脑区中的分布、摄取和组织结合并非均匀过程,它们可以部分解释临床上观察到的药效学和药代动力学之间的差异。数据还表明,心脏、肾脏和大脑中可能存在P特异性结合位点,这可能与其作用方式有关。